21 CFR Part 866 - Subpart G - Tumor Associated Antigen immunological Test Systems
prev | next
- § 866.6000 Whole exome sequencing constituent device.
- § 866.6010 Tumor-associated antigen immunological test system.
- § 866.6020 Immunomagnetic circulating cancer cell selection and enumeration system.
- § 866.6030 AFP-L3% immunological test system.
- § 866.6040 Gene expression profiling test system for breast cancer prognosis.
- § 866.6050 Ovarian adnexal mass assessment score test system.
- § 866.6060 BCR-ABL quantitation test.
- § 866.6070 Mutation detection test for myeloproliferative neoplasms.
- § 866.6080 Next generation sequencing based tumor profiling test.
- § 866.6090 Cancer predisposition risk assessment system.
- § 866.6100 DNA-based test to measure minimal residual disease in hematological malignancies.